Morgan Stanley downgraded Novo Nordisk to Underweight and kept a $40 target, which lowers analyst support for the shares.
Novo Nordisk was downgraded by Morgan Stanley from Equal-Weight to Underweight with a $40 price target. I read the downgrade and the lower target as a negative signal for how analysts view the stock.
JP Morgan downgraded Chewy from Overweight to Neutral and cut its price target, which reduces analyst optimism for Chewy.
UBS downgraded NuScale Power from Neutral to Sell and cut its price target, signaling weaker analyst views on the company.
JP Morgan downgraded Atmos Energy from Overweight to Neutral and trimmed the price target, which reduces analyst support for Atmos.
Follow Novo Nordisk A/S (NVO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for NVO